(Total Views: 260)
Posted On: 05/30/2017 2:37:04 PM
Post# of 72443
Re: someconcerns #34322
Yes, you saw it right. Almost $1B for a preclinical drug! The upfront payment structure is $50M now, $125M if it gets to Phase 2b, $200M after looking at interim data.
B-UP is a lock to advance to Phase 2b. Cha-ching!
B-UP is a lock to advance to Phase 2b. Cha-ching!
Quote:
J&J will pay Protagonist $125 million if it moves the drug into phase 2b and a further $200 million if it sticks with the asset after getting a look at data from the trial.
(2)
(0)
Scroll down for more posts ▼
